18 December 2018
Visiongain has launched a new pharma report Global Transplant Market Report : Tissue Products, Immunosuppressive Drugs, Preservation Solutions, Tissue Transplant, Organ Transplant, Heart Valve, Vascular Grafts, Bone Grafts, Cornea, Skin Grafts, Bone Marrow, Other Tissues, Kidney Transplant, Liver Transplant, Heart Transplant, Lung Transplant, Pancreas Transplant, Other Transplant, Hospitals, Transplant Centres, Other End-Users.
The worldwide rise in the demand for tissue or organs for transplant can be attributed to upsurge in the incidence of acute or chronic diseases. For instance, high blood pressure and diabetes are the foremost causes of end-stage kidney conditions, where kidney transplantation or dialysis is the solitary treatment possibilities to save a patient’s life. As stated by the National Kidney Foundation, there were approximately 122,737 patients in the U.S., who are waiting to receive organs for transplantation in 2014. Thus, there is growing demand for high-end tissue products for the treatment of organ damage or failure, and leukaemia treatment.
The lead analyst of the report commented "Rising number of transplant surgeries, escalating prevalence of chronic diseases, and developing healthcare infrastructure in emerging economies such as China, India, South Africa, Brazil, Mexico, and Indonesia are factors that will drive the demand for transplant products. However, factors such as lack of skilled professionals and high cost of organ transplant surgeries are expected to limit the market growth."
Leading companies featured in the report include AbbVie, Inc., Arthrex, Inc., Medtronic, Novartis AG, Stryker, Teva Pharmaceuticals, Veloxis Pharmaceuticals, Zimmer Biomet
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100.
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The market is expected to be driven by key factors such as rising cancer prevalence, government funding support in genetic research and technological advancements taking place in the biological research field. In addition, the market is predicted to gain huge traction in the developing countries.
11 May 2021
Strong product portfolio in the market is one of the major factors accelerating the growth of the market as availability of variants in the single-use systems allows targeted users more options.
11 May 2021
The growth in online shopping has been driven by a rapid rise in the number of smartphones, broadband connections and innovative payment products, although security remains the biggest concern. With the evolving market dynamics, merchants’ payment needs are also changing.
06 May 2021
Increasing investment in R&D for proteomics research, by both public and private organizations, is one of the major contributors to the growth of the protein labelling reagents market. The increasing prevalence of chronic diseases is also expected to contribute to the growth of this market.